|
Real-time Estimate
Cboe BZX
00:59:53 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.465 USD | -1.01% |
|
-7.37% | +25.65% |
| Market Cap | 659M 591M 546M 495M 925M 62.55B 936M 6.54B 2.6B 32.79B 2.47B 2.42B 104B | P/E 2026 * |
-8.71x | P/E 2027 * | -7.4x |
|---|---|---|---|---|---|
| Enterprise Value | 659M 591M 546M 495M 925M 62.55B 936M 6.54B 2.6B 32.79B 2.47B 2.42B 104B | EV / Sales 2026 * |
17.7x | EV / Sales 2027 * | 38.9x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | -1.01% | ||
| 1 week | -7.37% | ||
| Current month | -22.93% | ||
| 1 month | -23.95% | ||
| 3 months | -38.25% | ||
| 6 months | -12.95% | ||
| Current year | +25.65% |
| 1 week | 1.36 |  | 1.59 |
| 1 month | 1.36 | | 1.95 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 5.79 |
| 10 years | 0.28 | | 18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -7.37% | +5.47% | +20.42% | 659M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +82.12% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | |
| +1.73% | -0.18% | +26.59% | +55.86% | 44.75B | |
| +2.12% | -3.30% | +17.94% | +100.26% | 41.62B | |
| +0.24% | -4.05% | +220.47% | +915.91% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +3.77% | -1.01% | +46.94% | +147.41% | 38.11B | |
| Weighted average by Cap. | +2.97% | -0.30% | +46.92% | +159.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.17M 33.36M 30.81M 27.93M 52.21M 3.53B 52.85M 369M 147M 1.85B 140M 137M 5.87B | 16.93M 15.19M 14.03M 12.72M 23.78M 1.61B 24.07M 168M 66.8M 843M 63.54M 62.18M 2.67B |
| Net income | -73.77M -66.21M -61.13M -55.44M -104M -7.01B -105M -733M -291M -3.67B -277M -271M -11.65B | -97.05M -87.1M -80.43M -72.93M -136M -9.22B -138M -964M -383M -4.83B -364M -357M -15.32B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$1.445 | -2.36% | 386,806 |
| 27/10/26 | US$1.480 | +2.07% | 1,861,649 |
| 26/10/26 | US$1.450 | +2.11% | 2,205,901 |
| 23/10/26 | US$1.420 | -4.70% | 2,684,899 |
| 22/10/26 | US$1.490 | -4.49% | 1,320,441 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
